Coagadex Purple Book BLA 125506

BLA number
125506
Proprietary names
Coagadex
Proper names
Coagulation Factor X (Human)
Applicant
Bio Products Laboratory Limited
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001CoagadexCoagulation Factor X (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialRxLicensed2015-10-20
002CoagadexCoagulation Factor X (Human)351(a)250IUFor InjectionIntravenousSingle-Dose VialRxLicensed2015-10-20

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2024-08-01U001Coagadex351(a)RxBio Products Laboratory Limited
2024-08-01U002Coagadex351(a)RxBio Products Laboratory Limited
2023-06-01U001Coagadex351(a)RxBio Products Laboratory
2023-06-01U002Coagadex351(a)RxBio Products Laboratory
2021-09-01U001Coagadex351(a)RxBio Products Laboratory
2021-09-01U002Coagadex351(a)RxBio Products Laboratory
2021-05-01U001Coagadex351(a)RxBio Products Laboratory
2021-05-01U002Coagadex351(a)RxBio Products Laboratory
2020-08-01R001Coagadex351(a)RxBio Products Laboratory
2020-08-01R002Coagadex351(a)RxBio Products Laboratory

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Coagadex351(a)RxLicensed2015-10-20
2020-08-01002Coagadex351(a)RxLicensed2015-10-20